Sandra Notonier

Sandra Notonier currently serves as a Senior Scientist at Bonum Therapeutics, having joined the company in September 2022. Prior to this role, Sandra worked as a Scientist at Good Therapeutics, Inc. from November 2020 to September 2022, and as a Scientist II specializing in Cell Line and Upstream Development at SystImmune from August 2019 to November 2020. Earlier experience includes a position as a Postdoctoral Fellow at the National Renewable Energy Laboratory, focusing on the metabolic engineering of microbial pathways for biomass conversion. Sandra obtained a Ph.D. in Biochemistry from the University of Stuttgart, where research centered on biocatalysis and P450 monooxygenases. Additional training occurred at the Technical University of Denmark in bioengineering and internships at LS9, Inc. and CNRS.